907
Unity temporarily closes offices amid death threats following contentious pricing changes
(www.engadget.com)
this post was submitted on 14 Sep 2023
907 points (98.0% liked)
Technology
59345 readers
5327 users here now
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related content.
- Be excellent to each another!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, to ask if your bot can be added please contact us.
- Check for duplicates before posting, duplicates may be removed
Approved Bots
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Somehow I get the feeling that this may not just be some unhinged internet troll throwing out online drivel from his mom's basement. Unity's pricing changes are posing an existential threat to smaller studios that meet the minimum income threshold and are placing the livelihoods of countless thousands of smaller game studio workers at stake. This is one of those changes that is going to impact whether you can continue to put food on the table.
John Riccitello has pissed off a lot of people with his disgusting levels of corporate greed, to the point where even the fourth circle of Hell may not be enough to punish his avarice once he pops his clogs. This move may even be worse than the crap Martin Shkreli pulled as a big pharma executive.
It's bad, but it's not "denying medical treatment to millions of sick people because they can't pay" bad.
Martin gave the medication for free/reduced prices to people who couldn't afford it. It was literally a smear campaign.
Really? Everyone who couldn't afford it had access through him? This is certainly a revelation, and not something made up from the internet.
https://www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-interview